Genmab and AbbVie plan next steps for Epkinly in follicular lymphoma

Genmab and AbbVie plan next steps for Epkinly in follicular lymphoma

Submitted by admin on June 28, 2023 - 10:27am
Source: 
Clinical Trials Arena
News Tags: 
AbbVie
Genmab
Epkinly
clinical trials
relapsed or refractory follicular lymphoma
Headline: 
Genmab and AbbVie plan next steps for Epkinly in follicular lymphoma
snippet: 

Positive topline results were announced for the relapsed/refractory follicular lymphoma (FL) cohort of the Phase I/II EPCORE NHL-1 trial evaluating Genmab and AbbVie’s Epkinly (Epcoritamab-bysp).

Do Not Allow Advertisers to Use My Personal information